MedTrace Logo

German Registry for Transcatheter Tricuspid Valve Interventions

NCT04653428 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2020-12-04

No results posted yet for this study

Summary

Multicentre observational study of patients with severe tricuspid regurgitation and interventional treatment.

Conditions

  • Tricuspid Regurgitation
  • Tricuspid Valve Insufficiency
  • Heart Valve

Interventions

DEVICE

Interventional treatment of tricuspid regurgitation

Interventional treatment for tricuspid regurgitatin with CE-certified products, e.g. edge-to-edge repair

Sponsors & Collaborators

  • Heart and Diabetes Center North Rhine-Westphalia

    collaborator OTHER

  • Heart Center Leipzig - University Hospital

    collaborator OTHER

  • Mainz University

    collaborator OTHER

  • Universitätsklinikum Köln

    collaborator OTHER

  • University Hospital, Essen

    collaborator OTHER

  • LMU Klinikum

    lead OTHER

Principal Investigators

  • Jörg Hausleiter, MD · Klinikum der LMU Muenchen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2025-12-31
Completion
2030-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04653428 on ClinicalTrials.gov